top of page

Pharmaceutical patent search

  • Writer: Oleksandr Bragarnyk
    Oleksandr Bragarnyk
  • Jun 2, 2021
  • 1 min read

Updated: Oct 7, 2021

Bragarnyk & Partners IP serves dozens local and foreign pharmaceutical firms around the world to satisfy their demands in pharmaceutical patent search and IP information. Our foreign partners in other countries conduct expert patent research of intellectual property objects globally at the highest level of quality and reliability.

Patent research is conducted by a group of IP specialists experienced in the fields of pharmaceuticals, biotechnology, and medicine, specializing on preservation and protection of intellectual property rights (patent and trademark attorneys, lawyers-patent specialists, medical experts).

The success of the patent research on behalf of our customers primarily is dictated by awareness of pharmaceutical market specific features, based on years of interaction with both commercial and public entities of the market, regulatory authorities.

Moreover, thorough knowledge of national and global sources of the information in the field of intellectual property allows our professionals to conduct informational customer support, forestalling the world's leading providers at least for a month (on average - 6 months).

Why pharmaceutical patent search is so special and complex?

- Not always you can find name, formula or Reg.Num. of target substance.

Which IPC classes are biggest and complex? Where the highest numbers of applications?

- Over 50% of patent applications filed in fields related to pharmaceuticals and life sciences.

What the price of errors in patent search?

- In the IP field running concept of presumption of guilt of the user.


Recent Posts

See All
10 Urgent Questions

Question Impact on Economy Impact on Population 1 How to protect critical patents from being stolen by Russia? Direct link to national...

 
 
 
10 Popular Questions

Question Impact on Economy Impact on Population 1 Who owns developments funded by the state? Determines commercialization/export rights...

 
 
 

Comments


bottom of page